Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This is a pilot, randomized, double-blinded, placebo-controlled, 12-month trial of 50
patients with CKD stage 3b-4 with metabolic acidosis to examine the effect of sodium
bicarbonate therapy on cognitive and cerebrovascular function.